The term sheet agreement with GeneDiagnostics would cover marketing for the ColonSentry in Shanghai, Zhejiang, and Jiangsu.
Access will offer its web-based software with the Caliper LabChip GX system as an integrated molecular diagnostic platform.
Novartis Diagnostics will take the Bio-Seeq molecular diagnostic tests for infectious disease through clinical trials and on to commercialization.
Life Technologies will sell the kits for chromosomal abnormalities under the Applied Biosystems name. The agreement, however, does not include the US.
Enzo plans to seek approval for and market MultiGen's antenatal infectious disease tests in New York and in other US regions.
The exclusive sales and marketing agreement covers gene expression tests for inflammatory bowel disease and irritable bowel syndrome.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.